Vahan.ai Advances Multilingual AI Recruitment with NVIDIA Nemotron

▴ Vahan.ai Advances Multilingual AI Recruitment
Vahan.ai's multilingual AI recruiter developed in collaboration with NVIDIA technical experts to optimize NVIDIA Nemotron 3 Nano.

Vahan.ai, India's leading AI-powered recruitment platform for blue-collar and frontline workers, today announced a significant milestone in its AI journey. The company has fine-tuned the NVIDIA Nemotron 3 Nano open model for its AI recruiter, working closely with NVIDIA technical experts through the NVIDIA Inception program, strengthening multilingual hiring capabilities while enabling faster, more seamless candidate interactions. 

Vahan.ai's platform has enabled over 1.5 million job placements across 920+ cities in India, working with leading employers across quick commerce, food delivery, mobility, warehousing and manufacturing. To date, the platform has connected nearly 50 million Indians with employment opportunities.

At the heart of the platform is a voice-based AI recruiter capable of conducting human-like conversations with job seekers in English and Hindi over a simple phone call. The AI streamlines the hiring journey—from job discovery and application to interview scheduling—overcoming barriers related to digital literacy, language and infrastructure. Managing thousands of simultaneous conversations every day, Vahan.ai plans to further expand the platform to support eight additional Indian languages, making employment more accessible to first-time internet users and candidates across the country.

India's blue-collar recruitment landscape presents one of the most complex conversational AI challenges due to its linguistic diversity, regional dialects and varying employment contexts. To address this, Vahan.ai fine-tuned NVIDIA Nemotron 3 Nano using its proprietary production datasets of real, human-corrected multilingual recruitment conversations to optimize the model for recruitment-specific workflows and function execution.

The fine-tuning delivered significant improvements in multilingual recruitment performance. Benchmarking against multiple leading open-source and proprietary models across seven recruitment-critical parameters—including response correctness, function calling, human-like interactions, language matching and tool argument accuracy—showed that the model consistently outperformed both the base Nemotron model and the previous cloud-hosted 120-billion-parameter model being used by Vahan.ai. It also demonstrated stronger performance on unseen recruitment conversations, highlighting its ability to generalize beyond its training data while maintaining high conversational quality.

The optimized deployment also translated these gains into production efficiency, delivering nearly 6.7x faster time-to-first response and over 3x lower average end-to-end response latency while substantially reducing inference costs. Building on this milestone, Vahan.ai plans to develop specialized Small Language Models (SLMs) for recruitment and has established a continuous evaluation and fine-tuning pipeline that uses production conversations to continually improve model performance over time.

"At Vahan.ai, we're focused on building AI that is purpose-built for recruitment rather than relying solely on general-purpose language models," said Madhav Krishna, Founder and CEO of Vahan.ai. "Working closely with the NVIDIA team in India has enabled us to optimize NVIDIA Nemotron 3 Nano for one of the most complex conversational AI challenges - multilingual recruitment at scale. This is an important step in our journey towards building specialized language models for hiring that can deliver faster, more intuitive experiences for job seekers while helping us scale efficiently."

 

As Vahan.ai continues to advance its AI capabilities, the company remains focused on making hiring more accessible, efficient and inclusive through multilingual conversational AI tailored to India's frontline workforce.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026